110 related articles for article (PubMed ID: 10564073)
1. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation.
Bauer JF; Dziki W; Quick JE
J Pharm Sci; 1999 Nov; 88(11):1222-7. PubMed ID: 10564073
[TBL] [Abstract][Full Text] [Related]
2. Phase transformations of erythromycin A dihydrate during pelletisation and drying.
Römer M; Heinämäki J; Miroshnyk I; Sandler N; Rantanen J; Yliruusi J
Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405
[TBL] [Abstract][Full Text] [Related]
3. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
Patterson J; Bary A; Rades T
Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
[TBL] [Abstract][Full Text] [Related]
4. Phase transformation of erythromycin A dihydrate during fluid bed drying.
Römer M; Heinämäki J; Miroshnyk I; Kivikero N; Sandler N; Rantanen J; Yliruusi J
J Pharm Sci; 2008 Sep; 97(9):4020-9. PubMed ID: 18200525
[TBL] [Abstract][Full Text] [Related]
5. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
Otsuka M; Kanai Y; Hattori Y
J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
[TBL] [Abstract][Full Text] [Related]
6. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
7. Dissolution enhancement of tadalafil by liquisolid technique.
Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
[TBL] [Abstract][Full Text] [Related]
8. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
9. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
[TBL] [Abstract][Full Text] [Related]
10. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity.
Stephenson GA; Stowell JG; Toma PH; Pfeiffer RR; Byrn SR
J Pharm Sci; 1997 Nov; 86(11):1239-44. PubMed ID: 9383733
[TBL] [Abstract][Full Text] [Related]
11. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
[TBL] [Abstract][Full Text] [Related]
12. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
[TBL] [Abstract][Full Text] [Related]
13. Prediction of dissolution profiles by non-destructive near infrared spectroscopy in tablets subjected to different levels of strain.
Hernandez E; Pawar P; Keyvan G; Wang Y; Velez N; Callegari G; Cuitino A; Michniak-Kohn B; Muzzio FJ; Romañach RJ
J Pharm Biomed Anal; 2016 Jan; 117():568-76. PubMed ID: 26604167
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug dissolution from tablets using near-infrared diffuse reflectance spectroscopy as a nondestructive method.
Donoso M; Ghaly ES
Pharm Dev Technol; 2004 Aug; 9(3):247-63. PubMed ID: 15458231
[TBL] [Abstract][Full Text] [Related]
15. Physico-chemical characterization of interactions between erythromycin and various film polymers.
Sarisuta N; Kumpugdee M; Müller BW; Puttipipatkhachorn S
Int J Pharm; 1999 Sep; 186(2):109-18. PubMed ID: 10486428
[TBL] [Abstract][Full Text] [Related]
16. Enhanced dissolution of sildenafil citrate as dry foam tablets.
Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
[TBL] [Abstract][Full Text] [Related]
17. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
18. Application of near-infrared spectroscopy to optimize dissolution profiles of tablets according to the granulation mechanism.
Shikata F; Kimura S; Hattori Y; Otsuka M
Drug Dev Ind Pharm; 2018 May; 44(5):713-722. PubMed ID: 29192801
[TBL] [Abstract][Full Text] [Related]
19. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
20. Development and pharmacokinetic evaluation of erythromycin lipidic formulations for oral administration in rainbow trout (Oncorhynchus mykiss).
Serdoz F; Voinovich D; Perissutti B; Grabnar I; Hasa D; Ballestrazzi R; Coni E; Pellegrini E
Eur J Pharm Biopharm; 2011 Aug; 78(3):401-7. PubMed ID: 21402156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
